share_log

北京海润天睿律师事务所关于奥翔药业非公开发行股票发行过程和认购对象合规性之法律意见书

Legal opinion of Beijing Hairun Tianrui Law Firm on Aoxiang Pharmaceutical's non-public stock issuance process and subscription target compliance

Sensex a share ·  Jan 30, 2023 11:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more